Efficacy and safety of endoscopic intermuscular dissection for the treatment of rectal neuroendocrine tumors (with video)

VernacularTitle:内镜下肌间剥离术治疗直肠神经内分泌肿瘤效果及安全性的初步评价（含视频）
Author: Suhuan LIAO ¹ ; Jianzhen REN ; Guang YANG ; Bo LI ; Jun CAI ; Ronggang ZHANG ; Silin HUANG
Author Information

1. 深圳大学附属华南医院消化内科，深圳　518116
Keywords: Neuroendocrine tumors; Rectum; Endoscopic intermuscular dissection; Efficiency; Safety
From: Chinese Journal of Digestive Endoscopy 2024;41(11):906-909
CountryChina
Language:Chinese
Abstract: In order to preliminarily evaluate the efficacy and safety of endoscopic intermuscular dissection (EID) for the treatment of rectal neuroendocrine tumors (R-NETs), a retrospective observational study was conducted on 8 consecutive patients with R-NETs confirmed by postoperative pathology at South China Hospital, Medical School, Shenzhen University from January 2022 to October 2023. The therapeutic efficacy, incidence of complications, and follow-up results were mainly analyzed. The results showed that all 8 cases achieved complete resection after EID, with operation times ranging from 40 to 90 minutes. No bleeding, perforation, fever or electrocoagulation syndrome occurred after operation. The hospital stay was 4 to 6 days. During follow-up of 3 to 24 months, there was no local recurrence or metastasis. Therefore, a preliminary conclusion can be drawn that EID is a safe and feasible treatment for R-NETs.